• English
    • Deutsch
  • English 
    • English
    • Deutsch
  • Login
View Item 
  •   Home
  • Universität Ulm / Medizin
  • Publikationsnachweise
  • View Item
  •   Home
  • Universität Ulm / Medizin
  • Publikationsnachweise
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Bendamustine followed by obinutuzumab and venetoclax in chronic lymphocytic leukaemia (CLL2-BAG): primary endpoint analysis of a multicentre, open-label, phase 2 trial

Erstveröffentlichung
2018
Authors
Cramer, Paula
von Tresckow, Julia
Bahlo, Jasmin
Robrecht, Sandra
Langerbeins, Petra
et al.
Wissenschaftlicher Artikel


Published in
Lancet Oncology ; 19 (2018), 9. - S. 1215-1228. - ISSN 1470-2045. - eISSN 1474-5488
Link to publication
https://dx.doi.org/10.1016/S1470-2045(18)30414-5
Institutions
UKU. Klinik für Innere Medizin III
Subject headings
[Free subject headings]: minimal residual disease | in-vitro | ii trial | rituximab | ibrutinib | cyclophosphamide | fludarabine | cll | chemoimmunotherapy | progression
[DDC subject group]: DDC 610 / Medicine & health

Metadata
Show full item record

Policy | kiz service OPARU | Contact Us
Impressum | Privacy statement
 

 

Advanced Search

Browse

All of OPARUCommunities & CollectionsPersonsInstitutionsPublication typesUlm SerialsDewey Decimal ClassesEU projects UlmDFG projects UlmOther projects Ulm

My Account

LoginRegister

Statistics

View Usage Statistics

Policy | kiz service OPARU | Contact Us
Impressum | Privacy statement